by Jakub Jarolím, Business Intelligence Department
Dear customer, we are sorry but your browser doesn't support all necessary features for good site view. Please switch to one of the modern browsers (Chrome, Safari, Firefox).
Sotio Biotech
7/8/2024
July 2024 Biotechnology: Review of news from the most innovative therapeutic areas and the business development transactions
Market
Fed holds interest rates steady, but a cut is expected in coming months; NBI added 7 %
Buysiders and bankers are optimistic headed into 3Q24, as markets are rewarding positive catalysts. But uncertainty over the Fed’s timing on interest rate cuts is keeping a lid on how far the optimism can extend. Fed maintained rates steady, a cut is expected in coming months and NBI added 7 %.
Antibody-Drug Conjugates
Padcev plus Keytruda received positive CHMP opinion for first-line bladder cancer tretment
Astellas announced that EMA’s CHMP has adopted a positive opinion recommending approval of Padcev in combination with Keytruda for the first-line treatment of adult patients with unresectable or metastatic urothelial cancer, who are eligible for platinum-containing chemotherapy.
Interleukin-15 and Interleukin-2
Innovent presented Phase 1 data of its PD-1/IL-2α-bias bispecific antibody fusion protein
Egle Therapeutics, a biotech company focused on advancing the next generation of regulatory T cell-focused therapies for oncology and auto- immunity, will deliver an oral presentation at The Promise of Interleukin-2 Therapy meeting taking place in Paris.
Cell Therapies
Carvykti achieved statistically significant improvement in OS in CARTITUDE-4
Johnson & Johnson announced positive results from a prespecified second interim analysis of the Phase 3 CARTITUDE-4 study evaluating Carvykti (cilta-cel) compared to standard therapies of pomalidomide, bortezomib and dexamethasone (PVd) or daratumumab, pomalidomide and dexamethasone (DPd) for the treatment of patients with relapsed or lenalidomide-refractory multiple myeloma after one prior line of therapy.
Share on social networks